Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome

Patients with carcinoid tumors frequently could benefit from the pharmacologic treatment of depression and anxiety. However, many prescribers avoid serotonergic medications due to the theoretical risk of exacerbating carcinoid syndrome.

[1]  J. Wills,et al.  Retrospective Chart Review of Antidepressant Use in Patients with Carcinoid Tumors , 2017 .

[2]  Virginia A. Sadock,et al.  Kaplan and Sadock's Comprehensive Textbook of Psychiatry , 2017 .

[3]  R. S. Longman,et al.  Cognitive Impairment Associated With Carcinoid Syndrome , 2014, Annals of surgery.

[4]  vaishali patel,et al.  Article title with , 2013 .

[5]  R. S. Longman,et al.  Impairment of Cognitive Function Reported by Patients Suffering from Carcinoid Syndrome , 2010, World Journal of Surgery.

[6]  David Gross,et al.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers , 2009, Neuroendocrinology.

[7]  H. Boezen,et al.  Sexual Function in Patients with Metastatic Midgut Carcinoid Tumours , 2008, Neuroendocrinology.

[8]  A. Mee,et al.  Carcinoid syndrome unmasked by fluoxetine, a selective serotonin reuptake inhibitor. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  Suzanne R. Smith,et al.  Depression and Antidepressant Use in Gastrointestinal Carcinoid Cancer Patients1 , 2007 .

[10]  L. von Essen,et al.  Health related quality of life and psychosocial function among patients with carcinoid tumours. A longitudinal, prospective, and comparative study , 2007, Health and quality of life outcomes.

[11]  Mark D. Williams,et al.  Selective serotonin reuptake inhibitors and patients with carcinoid tumor. , 2005, Psychosomatics.

[12]  R. Balon,et al.  Carcinoid tumor, selective serotonin reuptake inhibitors, and diarrhea. , 2005, Psychosomatics.

[13]  J. Ajani,et al.  Carcinoid A Comprehensive Review , 2003, Acta oncologica.

[14]  J. A. Boer,et al.  Neuropsychological investigation into the carcinoid syndrome , 2003, Psychopharmacology.

[15]  L. Price,et al.  Acute changes in Cerebrospinal Fluid 5-HIAA following Oral Paroxetine Challenge in Healthy Humans , 2003, Neuropsychopharmacology.

[16]  L. von Essen,et al.  Health-related Quality of Life, Anxiety and Depression in Patients with Midgut Carcinoid Tumours , 2001, Acta oncologica.

[17]  A. Burroughs,et al.  Carcinoid tumour. , 1998, Lancet.

[18]  C. Noyer,et al.  Sertraline, a selective serotonin reuptake inhibitor, unmasking carcinoid syndrome. , 1997, The American journal of gastroenterology.

[19]  S. Sjöblom.  Clinical presentation and prognosis of gastrointestinal carcinoid tumours. , 1988, Scandinavian journal of gastroenterology.

[20]  J. Posner,et al.  Neurologic complications of carcinoid , 1986, Neurology.

[21]  W. Gunn.  Cancer: Principles and Practice of Oncology , 1982 .

[22]  Major Lf,et al.  Carcinoid and psychiatric symptoms. , 1973 .